Compare Indo-Rama Synthetics Tbk. (INDR) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo-Rama Synthetics Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Indo-Rama Synthetics Tbk. trades at Rp2,030 (market cap 1.33T, 2.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 2.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 2.6K). Which is the better fit depends on your goals.
| INDR | LABS | |
|---|---|---|
Market Cap | 1.33T | 576.7B |
Volume | 2.6K | 3.48M |
Lot | 26 | 34.82K |
Turnover | 5.29M | 522.79M |
Average Price | 2,033.08 | 150.13 |
Value | 5.29M | 522.79M |
Indicative Equilibrium Price | 2,030 | 148 |
Indicative Equilibrium Volume | 23 | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo-Rama Synthetics Tbk.
PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.
Read more on INDR →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
